The long-term effects of GHD on cardiovascular morbidity and mortality are unclear. However, adults with GHD have an increased fat mass and decreased lean body and bone mass, are often overweight, and have elevated lipids. GH treatment is also associated with reduced carotid intimal thickness and insulin insensitivity.[92]Colao A, Di Somma C, Spiezia S, et al. Growth hormone treatment on atherosclerosis: results of a 5-year open, prospective, controlled study in male patients with severe growth hormone deficiency. J Clin Endocrinol Metab. 2008 Sep;93(9):3416-24.
https://academic.oup.com/jcem/article/93/9/3416/2596763
http://www.ncbi.nlm.nih.gov/pubmed/18593773?tool=bestpractice.com
Cardiovascular mortality is increased in patients with hypopituitarism, particularly in women.[93]Rosen T, Bengtsson BA. Premature mortality due to cardiovascular disease in hypopituitarism. Lancet. 1990 Aug 4;336(8710):285-8.
http://www.ncbi.nlm.nih.gov/pubmed/1973979?tool=bestpractice.com
[94]Bülow B, Hagmar L, Eskilsson J, et al. Hypopituitary females have a high incidence of cardiovascular morbidity and an increased prevalence of cardiovascular risk factors. J Clin Endocrinol Metab. 2000 Feb;85(2):574-84.
https://academic.oup.com/jcem/article/85/2/574/2852741
http://www.ncbi.nlm.nih.gov/pubmed/10690858?tool=bestpractice.com
[95]Tomlinson JW, Holden N, Hills RK, et al. Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group. Lancet. 2001 Feb 10;357(9254):425-31.
http://www.ncbi.nlm.nih.gov/pubmed/11273062?tool=bestpractice.com
GH treatment can reverse and reduce many abnormalities.[80]Amato G, Carella C, Fazio S, et al. Body composition, bone metabolism, and heart structure and function in growth hormone (GH)-deficient adults before and after GH replacement therapy at low doses. J Clin Endocrinol Metab. 1993 Dec;77(6):1671-6.
http://www.ncbi.nlm.nih.gov/pubmed/8263158?tool=bestpractice.com
[81]Carroll PV, Christ ER, Bengtsson BA, et al. Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee. J Clin Endocrinol Metab. 1998 Feb;83(2):382-95.
https://academic.oup.com/jcem/article/83/2/382/2865179
http://www.ncbi.nlm.nih.gov/pubmed/9467546?tool=bestpractice.com
However, it is unclear whether treatment is associated with a reduction in the mortality.
Overview of acute coronary syndrome